Analysed ANI PHARMACEUTICALS INC (ANIP:NASDAQ) News Sources
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
23-09-2026
yahoo.com
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
23-09-2026
yahoo.com
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
30-09-2026
yahoo.com
Did FDA Approval of Generic Everolimus Suspension Just Shift ANI Pharmaceuticals' (ANIP) Investment Narrative?
07-10-2026
yahoo.com
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
12-10-2026
yahoo.com
What is the current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is $70.84.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is $-2.75.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is -3.7369%.
What is the most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is .
SEC-8K** Filing Available For ANI PHARMACEUTICALS INC (ANIP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.